menu

Medical Industry Feature: Recent Advances in the Use of Anti-EGFR for Metastatic Colorectal Cancer

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Recent Advances in the Use of Anti-EGFR for Metastatic Colorectal Cancer

Recent Advances in the Use of Anti-EGFR for Metastatic Colorectal Cancer
RestartResume

What are some of the recent advances that have impacted the use of anti-EGFR for metastatic colorectal cancer? An expert weighs in.

  • Overview

    This program is intended for healthcare professionals only and is supported by an independent educational grant from the Healthcare business of Merck KGaA, Darmstadt, Germany.

    Explore advances in the use of anti-EGFR for colorectal cancer, the role of tumor sidedness in treatment decisions, and clinical considerations when initiating adjuvant therapy with Professor Alberto Sobrero. 

    GBPMLR/NONO/1019/0043c

Facebook Comments

LIVE ON REACHMD RADIOBack to live radio

Loading...

Programs 4/7/20